GlassScriptPhysician profile
Nisreen A Jallad
NPI 1598943045
$11,785.08
in general payments reported to CMS, 2019-2025
32 companies · $4,668 in 2025
The $4,668 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $267 · 2021: $293 · 2022: $2,080 · 2023: $456 · 2024: $3,534 · 2025: $4,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,369 · Travel and Lodging: $4,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,369.04 |
| Travel and Lodging | $4,289.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,981.72 | 2019-2025 | Ekosonic, Watchman Flx, General - Thrombectomy |
| Medtronic, INC. | $3,209.93 | 2024-2025 | Turbohawk, Venaseal, Hawkone |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $887.10 | 2019-2025 | Lifevest |
| Penumbra, INC. | $703.93 | 2024-2025 | Indigo System, Penumbra System |
| Kestra Medical Technology Services, INC. | $443.27 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $418.25 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $398.37 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $329.77 | 2019-2025 | |
| Abbott Laboratories | $191.90 | 2020-2025 | Jot Dx, Esprit |
| Abiomed | $130.43 | 2023-2025 | Impella |
| Medtronic Vascular, INC. | $121.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $110.85 | 2019-2023 | Farxiga |
| Teleflex LLC | $106.00 | 2025 | Turnpike |
| Pfizer INC. | $99.41 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $95.79 | 2021-2023 | Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $92.28 | 2022 | |
| Stryker Corporation | $71.25 | 2025 | Flowtriever, Artix Mt |
| Amgen INC. | $53.89 | 2020-2022 | |
| Chiesi USA, INC. | $48.48 | 2024 | Kengreal |
| Angiodynamics, INC. | $44.06 | 2025 | Alphavac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.13 | 2020 | |
| Irhythm Technologies, INC. | $30.00 | 2019 | |
| Scpharmaceuticals INC. | $21.75 | 2023 | |
| Siemens Medical Solutions USA, INC. | $18.82 | 2024 | Artis Icono Floor |
| Sanofi-Aventis U.S. LLC | $17.96 | 2021 | |
| Cook Medical LLC | $17.24 | 2020 | |
| Lantheus Medical Imaging, INC. | $16.44 | 2022 | |
| Glaxosmithkline, LLC. | $15.40 | 2025 | Arexvy, Shingrix |
| Amarin Pharma, INC. | $15.11 | 2020 | |
| Cordis US Corp. | $13.66 | 2024 | Rain Sheath |
| Osprey Medical INC | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisreen Jallad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.